AGFA-GEVAERT NV (AGFB.BR) Stock Fundamental Analysis
Europe - EBR:AGFB - BE0003755692 - Common Stock
0.83 EUR
+0.01 (+1.22%)
We assign a fundamental rating of 3 out of 10 to AGFB. AGFB was compared to 10 industry peers in the Health Care Technology industry. The financial health of AGFB is average, but there are quite some concerns on its profitability. AGFB has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year AGFB has reported negative net income.
AGFB had a positive operating cash flow in the past year.
AGFB had negative earnings in 4 of the past 5 years.
AGFB had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
AGFB has a worse Return On Assets (-4.73%) than 70.00% of its industry peers.
With a Return On Equity value of -21.29%, AGFB is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.73% | ||
| ROE | -21.29% | ||
| ROIC | N/A |
ROA(3y)-8.91%
ROA(5y)0.06%
ROE(3y)-32.3%
ROE(5y)1.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AGFB's Operating Margin has declined in the last couple of years.
AGFB has a Gross Margin of 30.40%. This is amonst the worse of the industry: AGFB underperforms 80.00% of its industry peers.
AGFB's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AGFB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 30.4% |
OM growth 3Y-1.64%
OM growth 5Y-16.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.28%
GM growth 5Y0.88%
2. Health
2.1 Basic Checks
AGFB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AGFB has about the same amount of shares outstanding.
Compared to 5 years ago, AGFB has less shares outstanding
AGFB has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.27 indicates that AGFB is not a great score, but indicates only limited risk for bankruptcy at the moment.
AGFB has a Altman-Z score (2.27) which is in line with its industry peers.
AGFB has a Debt/Equity ratio of 0.63. This is a neutral value indicating AGFB is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, AGFB is doing worse than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.27 |
ROIC/WACCN/A
WACC8.93%
2.3 Liquidity
AGFB has a Current Ratio of 2.08. This indicates that AGFB is financially healthy and has no problem in meeting its short term obligations.
AGFB has a better Current ratio (2.08) than 70.00% of its industry peers.
AGFB has a Quick Ratio of 1.27. This is a normal value and indicates that AGFB is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.27, AGFB perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
The earnings per share for AGFB have decreased strongly by -79.00% in the last year.
AGFB shows a decrease in Revenue. In the last year, the revenue decreased by -0.35%.
The Revenue for AGFB have been decreasing by -10.44% on average. This is quite bad
EPS 1Y (TTM)-79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%763.5%
Revenue 1Y (TTM)-0.35%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.44%
Sales Q2Q%-1.75%
3.2 Future
The Earnings Per Share is expected to grow by 56.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.78% on average over the next years.
EPS Next Y109.52%
EPS Next 2Y77.28%
EPS Next 3Y56.83%
EPS Next 5YN/A
Revenue Next Year-1.29%
Revenue Next 2Y0.51%
Revenue Next 3Y1.21%
Revenue Next 5Y0.78%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AGFB. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 6.78, the valuation of AGFB can be described as very cheap.
Based on the Price/Forward Earnings ratio, AGFB is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AGFB to the average of the S&P500 Index (22.52), we can say AGFB is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 6.78 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AGFB is valued a bit more expensive than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 15.37 |
4.3 Compensation for Growth
AGFB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AGFB's earnings are expected to grow with 56.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.28%
EPS Next 3Y56.83%
5. Dividend
5.1 Amount
AGFB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EBR:AGFB (10/31/2025, 7:00:00 PM)
0.83
+0.01 (+1.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners51.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap128.50M
Revenue(TTM)1.13B
Net Income(TTM)-66000000
Analysts75.56
Price Target1.22 (46.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 6.78 | ||
| P/S | 0.11 | ||
| P/FCF | N/A | ||
| P/OCF | 3.67 | ||
| P/B | 0.41 | ||
| P/tB | 1.69 | ||
| EV/EBITDA | 15.37 |
EPS(TTM)-0.43
EYN/A
EPS(NY)0.12
Fwd EY14.75%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.23
OCFY27.24%
SpS7.27
BVpS2
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.73% | ||
| ROE | -21.29% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 30.4% | ||
| FCFM | N/A |
ROA(3y)-8.91%
ROA(5y)0.06%
ROE(3y)-32.3%
ROE(5y)1.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-1.64%
OM growth 5Y-16.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.28%
GM growth 5Y0.88%
F-Score3
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 12.13 | ||
| Cap/Depr | 105.26% | ||
| Cap/Sales | 3.56% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 218.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 2.27 |
F-Score3
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)78.36%
Cap/Depr(5y)64.97%
Cap/Sales(3y)3.26%
Cap/Sales(5y)2.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%763.5%
EPS Next Y109.52%
EPS Next 2Y77.28%
EPS Next 3Y56.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.35%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.44%
Sales Q2Q%-1.75%
Revenue Next Year-1.29%
Revenue Next 2Y0.51%
Revenue Next 3Y1.21%
Revenue Next 5Y0.78%
EBIT growth 1Y-650%
EBIT growth 3Y-14.94%
EBIT growth 5Y-25.35%
EBIT Next Year258.64%
EBIT Next 3Y64.43%
EBIT Next 5Y48.17%
FCF growth 1Y95.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.68%
OCF growth 3YN/A
OCF growth 5YN/A
AGFA-GEVAERT NV / AGFB.BR FAQ
What is the fundamental rating for AGFB stock?
ChartMill assigns a fundamental rating of 3 / 10 to AGFB.BR.
What is the valuation status of AGFA-GEVAERT NV (AGFB.BR) stock?
ChartMill assigns a valuation rating of 4 / 10 to AGFA-GEVAERT NV (AGFB.BR). This can be considered as Fairly Valued.
How profitable is AGFA-GEVAERT NV (AGFB.BR) stock?
AGFA-GEVAERT NV (AGFB.BR) has a profitability rating of 1 / 10.
What is the financial health of AGFA-GEVAERT NV (AGFB.BR) stock?
The financial health rating of AGFA-GEVAERT NV (AGFB.BR) is 4 / 10.